Financials
- Market Capitalization 419.39 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.14
売上高対価格比率
26.03
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3023 | BNTC Benitec Biopharma Inc. - Common Stock | 12.67 USD | -1.63% | -3.58% | +5.50% | -23.72% | 435.27 M USD | ||
| 3048 | LRMR Larimar Therapeutics, Inc. - Common Stock | 4.05 USD | -2.88% | -3.80% | +6.30% | +3.32% | 420.73 M USD | ||
| 3052 | GALT Galectin Therapeutics Inc. - Common Stock | 4.14 USD | -0.24% | +14.36% | +20.70% | -1.43% | 417.52 M USD | ||
| 3062 | FENC Fennec Pharmaceuticals Inc. - Common Stock | 11.77 USD | -3.29% | +2.62% | +17.00% | +31.36% | 412.74 M USD |